Cargando…
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors
Purpose: Cognitive impairment in cancer patients induced, at least in part, by treatment are frequently observed and likely have negative impacts on patient quality of life. Such cognitive dysfunctions can affect attention, executive functions, and memory and processing speed, can persist after trea...
Autores principales: | Castel, Hélène, Denouel, Angeline, Lange, Marie, Tonon, Marie-Christine, Dubois, Martine, Joly, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359273/ https://www.ncbi.nlm.nih.gov/pubmed/28377717 http://dx.doi.org/10.3389/fphar.2017.00138 |
Ejemplares similares
-
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
por: Lange, Marie, et al.
Publicado: (2022) -
Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice
por: Dubois, Martine, et al.
Publicado: (2014) -
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
por: Lange, Marie, et al.
Publicado: (2017) -
The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
por: Nicola, Celeste, et al.
Publicado: (2021) -
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database
por: Prevost, Rachel, et al.
Publicado: (2023)